Search

In this video interview, Mike Rea explains why each drug needs its own launch strategy.

After nine months of speculation about who will be the next FDA commissioner, we may finally be close to a decision.

A Korean team have conducted a study on a peptide that could help to produce medicines capable of crossing cell membranes and interfering with PPIs.

There’s a lot going on in the world of biopharma but never fear because we’ve got you covered…

The way the pharma industry has traditionally handled clinical trials does not make participation easy.

We speak with the authors of two studies into extreme increases in US drug pricing, and attempts by lawmakers to bring the price-jackers into line.

What lessons were learned from Operation Warp Speed?

With the threat of COVID-19, vaccine developers needed to enter clinical development and scale-up at unprecedented speed.

We get the lowdown on the Reputation Index, which was recently published by the Association of the British Pharmaceutical Industry.

The pharma industry is one of the biggest targets for cybercrime. How can companies avoid succumbing to attack?